Dysgraphia described after sertraline intake
(HealthDay)—Dysgraphia after sertraline intake has been documented in a case report published online Jan. 21 in the Journal of Clinical Pharmacy and Therapeutics.
Jan 26, 2016
0
2
(HealthDay)—Dysgraphia after sertraline intake has been documented in a case report published online Jan. 21 in the Journal of Clinical Pharmacy and Therapeutics.
Jan 26, 2016
0
2
Regions of the brain that normally work together to process emotion become decoupled in people who experience multiple episodes of depression, neuroscientists report. The findings may help identify which patients will benefit ...
Jan 20, 2016
1
130
A large-scale survey of U.S. adults provides no evidence that levels of depressive symptoms vary from season to season, according to new research published in Clinical Psychological Science, a journal of the Association for ...
Jan 20, 2016
0
6
Negative body image significantly increases the risk of obesity regardless of whether youth have depression, according to researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public ...
Nov 9, 2015
0
15
If you're feeling a little blue during the transition to menopause, there's good reason, according to a new study being reported online today in Menopause, the journal of The North American Menopause Society (NAMS). The study ...
Nov 4, 2015
0
18
People who have had an episode of major depression are at high risk for having another episode. Now, researchers at University of California, San Diego School of Medicine have found that the risk of recurrence is significantly ...
Oct 27, 2015
0
25
Scientists from the RIKEN Brain Science Institute have shown that a mouse strain with a mutation that leads to dysfunction of mitochondria—the "powerhouses" that provide energy to cells—spontaneously undergo periodic ...
Oct 20, 2015
0
61
Functional magnetic resonance imaging (fMRI) could be used to predict which patients with recovered major depressive disorder are most likely to have more depressive episodes, according to a study published today in JAMA ...
Oct 8, 2015
0
21
A cognitive-behavioral prevention program for depression among at-risk youth showed benefit more than 6 years after the implementation of the intervention, according to an article published online by JAMA Psychiatry.
Sep 30, 2015
0
27
Brexpiprazole, an antipsychotic drug approved this summer by the U.S. Food and Drug Administration, is an effective and well-tolerated addition to conventional first-line antidepressants for the treatment of major depressive ...
Aug 27, 2015
0
17